Intrathecal baclofen in cerebral palsy movement disorders
- PMID: 8959459
- DOI: 10.1177/0883073896011001S05
Intrathecal baclofen in cerebral palsy movement disorders
Abstract
Intrathecal baclofen reduces spasticity in individuals with cerebral palsy. Intrathecal doses are far lower than oral doses and the effects are considerably greater, and the side effects are fewer. Response to intrathecal baclofen must be confirmed by a screening trial before implantation of a pump for chronic infusion. Intrathecal baclofen reduces spasticity in the upper and lower extremities and is often associated with improved gait and upper extremity function. Quality of life improves for patients and caregivers. The Medtronic pump has been exceedingly reliable and typically functions for 4 or 5 years. The currently available intrathecal catheter is associated with far fewer complications than the initial catheter. Baclofen overdoses are unusual and are usually caused by pump programming errors rather than pump malfunction. Preliminary studies suggest that continuous intrathecal baclofen infusion reduces generalized dystonia in cerebral palsy. Screening to determine response of dystonia to intrathecal baclofen is by continuous infusion. The doses required to reduce dystonia are higher than those for cerebral spasticity. Additional investigations are underway to quantify the effects of continuous intrathecal baclofen infusion on communication, disability, and dystonia.
Similar articles
-
Baclofen in the treatment of cerebral palsy.J Child Neurol. 1996 Mar;11(2):77-83. doi: 10.1177/088307389601100202. J Child Neurol. 1996. PMID: 8881981
-
Improvements in children with cerebral palsy following intrathecal baclofen: use of the Rehabilitation Institute of Chicago Care and Comfort Caregiver Questionnaire (RIC CareQ).J Child Neurol. 2014 Mar;29(3):312-7. doi: 10.1177/0883073812475156. Epub 2013 Feb 17. J Child Neurol. 2014. PMID: 23420651
-
[Intrathecal baclofen for treatment of spasticity in patient with cerebral palsy--a preliminary report].Chir Narzadow Ruchu Ortop Pol. 2003;68(4):253-9. Chir Narzadow Ruchu Ortop Pol. 2003. PMID: 14702678 Polish.
-
Clinical practices in intrathecal baclofen pump implantation in children with cerebral palsy in France.Ann Phys Rehabil Med. 2016 Sep;59(4):282-4. doi: 10.1016/j.rehab.2016.02.009. Epub 2016 May 4. Ann Phys Rehabil Med. 2016. PMID: 27158102 Review. No abstract available.
-
Scoliosis, spinal fusion, and intrathecal baclofen pump implantation.Phys Med Rehabil Clin N Am. 2015 Feb;26(1):79-88. doi: 10.1016/j.pmr.2014.09.003. Phys Med Rehabil Clin N Am. 2015. PMID: 25479781 Review.
Cited by
-
Subfascial expansive plasty for intrathecal baclofen pump replacement. A technical note.J Spinal Cord Med. 2016;39(1):118-20. doi: 10.1179/2045772315Y.0000000019. Epub 2015 May 3. J Spinal Cord Med. 2016. PMID: 25936401 Free PMC article.
-
Cerebral Palsy.Curr Treat Options Neurol. 2000 Mar;2(2):97-108. doi: 10.1007/s11940-000-0011-4. Curr Treat Options Neurol. 2000. PMID: 11096740
-
Reliability of Ashworth and Modified Ashworth scales in children with spastic cerebral palsy.BMC Musculoskelet Disord. 2008 Apr 10;9:44. doi: 10.1186/1471-2474-9-44. BMC Musculoskelet Disord. 2008. PMID: 18402701 Free PMC article.
-
Understanding the reasons for delayed referral for intrathecal baclofen therapy in pediatric patients with severe spasticity.Childs Nerv Syst. 2015 Mar;31(3):405-13. doi: 10.1007/s00381-014-2591-4. Epub 2014 Nov 16. Childs Nerv Syst. 2015. PMID: 25398671
-
Pharmacological and neurosurgical interventions for individuals with cerebral palsy and dystonia: a systematic review update and meta-analysis.Dev Med Child Neurol. 2021 Sep;63(9):1038-1050. doi: 10.1111/dmcn.14874. Epub 2021 Mar 27. Dev Med Child Neurol. 2021. PMID: 33772789 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical